Secondary M yeloid L eukemia a nd M yelodysplastic S yndromes in P atients T reated f or H odgkin's D isease: A R eport F rom t he German H odgkin's L ymphoma S tudy G roup
暂无分享,去创建一个
V. Diehl | J. Franklin | J. Wolf | M. Sieber | A. Engert | A. Josting | M. May | S. Wiedenmann
[1] J. Friedberg,et al. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. , 2002, Blood.
[2] A. Hagemeijer,et al. Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS. , 2001, Blood.
[3] H. Deeg,et al. Hematopoietic stem-cell transplantation for treatment-related leukemia or myelodysplasia. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] V. Diehl,et al. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] J. Rowe,et al. Biology and therapy of secondary leukaemias. , 2001, Best practice & research. Clinical haematology.
[6] D. Neuberg,et al. Assessment of the stanford V regimen and consolidative radiotherapy for bulky and advanced Hodgkin's disease: Eastern Cooperative Oncology Group pilot study E1492. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] T. Lister,et al. Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] W. Wilmanns,et al. Second malignancies after Hodgkin's disease: the Munich experience , 1999, Annals of Hematology.
[9] S. Mackinnon,et al. A non myeloablative regimen for allografting high-risk patients: Low toxicity, stable engraftment without GVHD, disease control and potential for GVL with adoptive immunotherapy. , 1999 .
[10] J. Gribben,et al. Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] N. Schmitz,et al. Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT , 1999, British journal of haematology.
[12] C. Gisselbrecht,et al. Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease. , 1998, Blood.
[13] N. Ueno,et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] C. Harrison,et al. Outcome of secondary myeloid malignancy in Hodgkin's disease: the BNLI experience , 1998, European journal of haematology.
[15] R. Storb,et al. Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy. , 1997, Blood.
[16] A. Hagenbeek,et al. Second cancer risk following Hodgkin's disease: a 20-year follow-up study. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] P. Valagussa. Second neoplasms following treatment of Hodgkin's disease , 1993, Current opinion in oncology.
[18] K. Propert,et al. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. , 1992, The New England journal of medicine.
[19] M J Ratain,et al. Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: from the bedside to the target genes. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.
[20] A. Neugut,et al. Poor survival of treatment-related acute nonlymphocytic leukemia. , 1990, JAMA.
[21] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .